Organic Active Ingredients TRIZ Cases

Bacterially fermented hemp pomace delivers cannabinoids within a natural fiber matrix, avoiding solvent residues and preserving compound synergy.

Enzymatic sulfation modifies bovine heparin structure to increase anticoagulant activity and meet USP specifications.

Adding tannins to simplified nutrition restores mucosal barrier integrity by counteracting immune suppression caused by elemental feeding.

HMWHA eye drops with intrinsic viscosity at least 2.5 m3/kg restore damaged corneal nerves without expensive infrastructure.

Bicyclic compounds selectively inhibit histone deacetylase 2 to enhance synaptic density while avoiding nonspecific effects on other isoforms.

Amino and chloro substitutions on benzazoloquinolium salts enhance tumor selectivity while maintaining reliable autofluorescence for cancer diagnostics.

Targeted SHP2 inhibitors regulate cytokine signaling to reduce organ damage and improve survival in systemic lupus erythematosus.

Recombinant anti-CCR4 antibody combined with Lenalidomide targets CCR4-expressing T-cell lymphoma cells via antibody-dependent cellular cytotoxicity.

Feeding dsRNA triggers RNA interference to degrade parasite mRNA, eliminating toxic side effects and resistance associated with chemical treatments.

Substituted indole compounds inhibit Toll-like receptor 7, 8, and 9 signaling to treat inflammatory diseases.

Histone methyltransferase inhibitors modulate epigenetic states to reduce drug resistance in integrin beta 3 expressing cancer stem cells.

Carbamate mibefradil analogs inhibit T-type calcium channels, overcoming traditional antagonist limitations in cancer treatment.

A tablet formulation uses selexipag form P with a 1 to 150 µm particle size to enhance dissolution and bioavailability.

DOTAP liposomes complex with plasmid DNA to enable oral vaccination of fish, eliminating the stress and cost of intramuscular injection.

Oral composition combining krill oil, astaxanthin, and hyaluronic acid to alleviate joint pain.

Imidazopyridine compounds modulate P2X3 receptors, resolving the trade-off between therapeutic effectiveness and safety concerns in pain treatment.

Adjusting the buffer pH to 6.8–8.3 prevents lidocaine precipitation, maintaining bioavailability for urinary tract treatment.

Fluorinated isoxazolidine ring modification extends duration of action while reducing systemic side effects in inhaled corticosteroids.

Trimetazidine prevents contrast-induced acute kidney injury by shifting mitochondrial metabolism toward glucose utilization.

Bicyclic derivatives target the GABAA α5 receptor to treat cognitive disorders while avoiding sedation and amnesia side effects.

Liver-targeted DNP derivatives increase mitochondrial activity in hepatocytes, resolving systemic toxicities like hypothermia while treating NAFLD.

Bis-heteroaryl derivatives inhibit protein aggregation by targeting specific regions of misfolded proteins like alpha-synuclein.

Dimethylsulfoxide dissolves eprinomectin for stable injection, eliminating milk withdrawal periods in lactating dairy cows.

Analyzing TET2 mutations and protein expression resolves diagnostic reliability issues in early myeloid and lymphoid tumor detection.

Segmenting molecules with intermediary oligomers reduces blood-brain barrier penetration while maintaining therapeutic efficacy.

A deoxycholic acid formulation reduces residual vascular lesion size through targeted intralesional injection.

Small molecule ligands replace complex antibodies in B-L-A conjugates, resolving manufacturing trade-offs while targeting hypoxic tumors.

Combining neurotoxins with local anesthetics in a stellate ganglion block extends relief duration beyond immediate anesthetic effects.

Specific levan oligomers restore compromised skin barrier function against environmental damage while reducing wrinkle formation.

Optimizing pH with citrate buffer prevents discoloration in metoclopramide nasal solutions.

A pyrazolo[3,4-d]pyrimidine composition inhibits HCK and FLT3 kinases to eliminate leukemia stem cells.

Naphthoquinone-based chalcone derivatives stabilize ATP production through targeted redox reactions within the mitochondrial electron transport chain.

Pyrazolopyrimidine compounds inhibit BLK and Btk kinases, reducing autoantibody production and bone destruction while avoiding permanent B cell loss.

A crystalline Olaparib form incorporating benzyl alcohol within its lattice structure to enhance solubility.

A pharmaceutical composition combines anti-cytokine antibodies with mesenchymal stromal cell-derived proteins to neutralize inflammatory signals.

Segmenting intact immunoglobulins into C1ORF32 antibody fragments improves tumor penetration and overcomes regulatory cell inhibition.

Computational design of modified nucleic acids inhibits LPA gene expression, lowering Lp(a) levels to reduce cardiovascular disease risk.

Oral formulation merging benzodiazepine and NMDA antagonist overcomes insufficient anesthetic efficacy of single-agent therapy.

Formula I sterol derivatives protect neurons from hypoxic damage at picomolar concentrations.

Small molecule adjuvants induce TNF-alpha secretion in macrophages via TLR4-independent pathways.

Ultraviolet irradiation converts extracted ergosterol to vitamin D2, addressing limited natural dietary sources and low vitamin D content in food.

A carbosiloxane dendrimer copolymer with long-chain alkyl groups improves cosmetic formulation stability and miscibility.

Serum ethanolamine phospholipid levels detect early Alzheimer's pathology, replacing invasive brain biopsies with non-invasive blood testing.

Aryl-fused spirocyclic compounds overcome insufficient potency and bioavailability of hydroxamic acid derivatives by optimizing molecular structure.

Benzimidazole derivatives inhibit ITK via covalent binding to Cys442, addressing insufficient therapeutic efficacy in inflammatory disorders.

Characterizing Form-I and Form-II crystal polymorphs via X-ray diffraction ensures consistent drug quality while reducing screening time.

Exosome-loaded antisense oligonucleotides reduce CEBPβ expression while minimizing immunogenic responses.

Estetrol treatment alleviates dysmenorrhea while reducing venous thromboembolism risk compared to synthetic estrogens.

Removing acid and organic washes reduces production time while maintaining native cell wall structure.